Literature DB >> 9602305

Transcriptional control during T-cell development.

H Clevers1, P Ferrier.   

Abstract

During the past few years, the essential role of distinct transcription factors in specifying cell-fate decisions in a stepwise fashion during T-cell differentiation has been revealed. One striking feature is that a single factor can act at several sites throughout T-cell development, possibly through interactions with different partners. The challenge is now to understand how these interactions can account for the co-ordination of complex extracellular signals and gene expression programs, such as those involved in T-cell receptor gene recombination and expression.

Mesh:

Year:  1998        PMID: 9602305     DOI: 10.1016/s0952-7915(98)80245-8

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  5 in total

1.  c-Cbl deficiency leads to diminished lymphocyte development and functions in an age-dependent manner.

Authors:  Chozhavendan Rathinam; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

2.  Definition of a T-cell receptor beta gene core enhancer of V(D)J recombination by transgenic mapping.

Authors:  R K Tripathi; N Mathieu; S Spicuglia; D Payet; C Verthuy; G Bouvier; D Depetris; M G Mattei; W M HempeL; P Ferrier
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

Review 3.  The role of orphan nuclear receptor in thymocyte differentiation and lymphoid organ development.

Authors:  Y W He
Journal:  Immunol Res       Date:  2000       Impact factor: 4.505

4.  Expression of the mouse pre-T cell receptor alpha gene is controlled by an upstream region containing a transcriptional enhancer.

Authors:  B Reizis; P Leder
Journal:  J Exp Med       Date:  1999-05-17       Impact factor: 14.307

5.  Activation of the p38 mitogen-activated protein kinase pathway arrests cell cycle progression and differentiation of immature thymocytes in vivo.

Authors:  N L Diehl; H Enslen; K A Fortner; C Merritt; N Stetson; C Charland; R A Flavell; R J Davis; M Rincón
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.